DEA Denver Field Division Investigates Walgreens As Part Of National Investigation; Settlement Announced In Which Walgreens Agrees To Pay $80 Million For Violations Of The Controlled Substances Act
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • DEA Denver Field Division Investigates Walgreens As Part Of National Investigation; Settlement Announced In Which Walgreens Agrees To Pay $80 Million For Violations Of The Controlled Substances Act

DEA Denver Field Division Investigates Walgreens As Part Of National Investigation; Settlement Announced In Which Walgreens Agrees To Pay $80 Million For Violations Of The Controlled Substances Act

Junio 12, 2013
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Steffan W. Tubbs
Phone Number: 571-387-5079

DENVER - Walgreens (Walgreens), the nation’s largest drug store chain, has agreed to pay $80 million in civil penalties for violations of the Controlled Substances Act, resolving an investigation in which the United States Attorney’s Office for the District of Colorado and the DEA’s Denver Field Division participated.  The agreement was announced by the United States Attorney’s Office for the Southern District of Florida.  The United States Attorney’s Offices in the Eastern District of Michigan and the Eastern District of New York also participated.   

The DEA Denver Field Division and the Colorado U.S. Attorney’s Office identified more than 1,600 violations of the Controlled Substances Act at Walgreens stores located in Colorado.  The majority of these violations were found at Walgreens stores located in Canon City and Pueblo.  The investigation uncovered instances of Walgreens stores filling fraudulent prescriptions, filling prescriptions written by a physician with an expired DEA registration, filling prescriptions lacking an address and/or DEA registration number in violation of DEA regulations, and dispensing controlled substances to customers without a prescription.  The investigation also uncovered hundreds of examples of inaccurate or incomplete recordkeeping for controlled substances at Walgreens stores located throughout Colorado.  Such inaccurate or incomplete recordkeeping violates the Controlled Substances Act. 

“Accurate and efficient record-keeping and administrative procedures are critical for the safe dispensing and use of pharmaceutical drugs.  As this case shows, DEA will ensure that DEA registrants adhere to the law to protect public health and safety, or face the consequences for failing to do so,” said Barbra Roach, Special Agent in Charge of the DEA’s Denver Division.

“Stores that sell controlled substances must keep careful track of their inventory,” said U.S. Attorney John Walsh.  “Those that don’t, like Walgreens in this case, face severe penalties, like the record $80 million penalty announced today.”
Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

David S. Olesky Special Agent in Charge - Rocky Mountain
@DEAROCKYMTNDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster